15-03-2023, 07:18

Tango Therapeutics to Highlight Preclinical Data on

BOSTON, March 14, 2023 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX) today announced the acceptance of
Globe Newswire15-03-2023, 07:18
15-03-2023, 05:27

Harpoon Therapeutics Announces Acceptance of Five Abstracts

Preclinical abstracts for investigational T cell engagers, HPN328 and HPN217, in mouse models provide further
Globe Newswire15-03-2023, 05:27
15-03-2023, 05:12

Kinnate Biopharma Inc. to Report First Clinical Data for

Company has initiated enrollment of patients into the monotherapy expansion cohorts Company to host a virtual investor
Globe Newswire15-03-2023, 05:12
15-03-2023, 05:09

CRISPR Therapeutics to Present at the American Association

ZUG, Switzerland and BOSTON, March 14, 2023 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a
Globe Newswire15-03-2023, 05:09
15-03-2023, 04:41

Kura Oncology Announces Acceptance of Two Abstracts for

– Presentations to highlight preclinical data supporting combination of FTIs with KRASG12C inhibitors and tyrosine
Globe Newswire15-03-2023, 04:41
15-03-2023, 03:58

Nurix Therapeutics Announces Presentations at the American

Nurix to report additional preclinical data for its targeted BTK degraders NX-2127 and NX-5948...
Globe Newswire15-03-2023, 03:58
15-03-2023, 03:57

Sana Biotechnology Announces the Acceptance of Four

Late-breaking poster presentation to highlight preclinical data demonstrating that the increased potency of
Globe Newswire15-03-2023, 03:57
15-03-2023, 03:39

Cullinan Oncology to Present New Preclinical Data for

CLN-619 is a MICA/B directed humanized IgG1 antibody being studied in a global Phase 1 clinical trial in patients with
Globe Newswire15-03-2023, 03:39
15-03-2023, 03:07

The Lovesac Company to Announce Fourth Quarter and Fiscal

STAMFORD, Conn., March 14, 2023 (GLOBE NEWSWIRE) -- The Lovesac Company (Nasdaq: LOVE) today announced that its fourth
Globe Newswire15-03-2023, 03:07
15-03-2023, 03:04

Adamis Pharmaceuticals Schedules Fourth Quarter and Full

SAN DIEGO, March 14, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage
Globe Newswire15-03-2023, 03:04
14-03-2023, 23:02

Ed Mylett to Inspire and Motivate as Keynote Speaker at

Find your true path with Ed Mylett at eXp Shareholder Summit, May 17-20, 2023 in Orlando, FL...
Globe Newswire14-03-2023, 23:02
14-03-2023, 19:07

LumiraDx to Announce Fourth Quarter and Full Year 2022

LONDON, March 14, 2023 (GLOBE NEWSWIRE) -- LumiraDx Limited (Nasdaq: LMDX), a next-generation point of care (POC)
Globe Newswire14-03-2023, 19:07